pentadecapeptide BPC 157

• Post Date:

  Aug 21,2015

• Expiry Date:

  Feb 17,2016

• Detailed Description:

  pentadecapeptide BPC 157
  email:jaymee at ycphar dot com.
  Alias: Booly Protection Compound 15, Pentadecapeptide, BPC 157
  CAS: 137525-51-0
  Sequence: Gly-Glu-Pro-Pro-Pro-Gly- Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
  MF: C62H98N16O22
  MW: 1419.53552
  Purity: 99%
  Specification: 2mg/vial
  Appearance: White Lyophilized Powder
  Place of Origin: China
  Standard: USP
  Certification: SGS
  Method of Analysis: HPLC
  Storage: Lyophilized peptides although stable at room temperature for 3 months, should be stored desiccated below -18° C. Upon reconstitution of the peptide it should be stored at 4° C between 2-21 days and for future use below -18° C.
  
  
  BPC 157 has a strong anti-inflammatory activity in both acute and chronic inflammation models. In fact, preliminary results in clinical trials suggest that BPC 157 may become an important therapeutic tool for the treatment of inflammatory bowel disease. BPC 157 was shown to accelerate wound healing and to have a marked angiogenic effect.
  
  In addition, it significantly facilitates the healing of bone fracture in rats. This peptide also exhibits an osteogenic effect significantly improving the healing of segmental bone defect. BPC 157 accelerates the healing of transected rat Achilles tendon and transected rat quadriceps muscle.
  
  FITC-phalloidin staining was able to demonstrate that BPC 157 induces F-actin formation in fibroblasts. Likewise, Western blot analysis was able to detect the production and activation of paxillin and FAK proteins. The western blot analysis also showed that BPC 157 increases the extent of phosphorylation of paxillin and FAK proteins without affecting the amounts produced.
  

• Company:

  Hubei Yuancheng Saichuang Technology Co., Ltd     [ China ]        

• Contact:

  laukenny

• Tel:

  86-027-50756221

• Fax:

  86-027-68886696

• Email:

  jaymee@ycphar.com